Literature DB >> 15026158

Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents.

Yoshio Matsumoto1, Michiko Abe, Takuya Watanabe, Yuka Adachi, Takahiko Yano, Hideki Takahashi, Tsukasa Sugo, Masaaki Mori, Chieko Kitada, Tsutomu Kurokawa, Masahiko Fujino.   

Abstract

We identified urotensin II (U-II) as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 or SENR. Both U-II and GPR14 are expressed not only in peripheral tissues but also in the brain of rodents, suggesting that U-II plays a physiological role in the central nervous system. In the present study, we investigated the central effects of U-II in rodents. Intracerebroventricular administration of U-II induced anxiogenic-like behaviors in the elevated plus maze test and the hole-board test in mice in a dose-dependent manner, as did corticotropin releasing factor (CRF). The effective doses of U-II were 10-100-fold higher than these of CRF in these tests. Our results suggest that U-II is a candidate for the mediator of some aspect of stress or anxiety in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026158     DOI: 10.1016/j.neulet.2003.12.116

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).

Authors:  Valeria Camarda; Martina Spagnol; Wei Song; Raffaella Vergura; Adelheid L Roth; Jonathan P Thompson; David J Rowbotham; Remo Guerrini; Erika Marzola; Severo Salvadori; Paolo Cavanni; Domenico Regoli; Stephen A Douglas; David G Lambert; Girolamo Calò
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 2.  A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects.

Authors:  Benjamin D Hunt; Leong L Ng; David G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-27       Impact factor: 3.000

3.  Behavioral effects of urotensin-II centrally administered in mice.

Authors:  Jean-Claude Do-Rego; David Chatenet; Marie-Hélène Orta; Bertrand Naudin; Camille Le Cudennec; Jérôme Leprince; Elizabeth Scalbert; Hubert Vaudry; Jean Costentin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

4.  Urotensin II stimulates plasma extravasation in mice via UT receptor activation.

Authors:  Raffaella Vergura; Valeria Camarda; Anna Rizzi; Martina Spagnol; Remo Guerrini; Girolamo Calo'; Severo Salvadori; Domenico Regoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-23       Impact factor: 3.000

5.  Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.

Authors:  Shawn M Vuong; Harvey A Oliver; Jamie L Scholl; Kathryn M Oliver; Gina L Forster
Journal:  Behav Brain Res       Date:  2009-12-01       Impact factor: 3.332

6.  Urotensin-related gene transcripts mark developmental emergence of the male forebrain vocal control system in songbirds.

Authors:  Zachary W Bell; Peter Lovell; Claudio V Mello; Ping K Yip; Julia M George; David F Clayton
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

7.  Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents.

Authors:  Jodi L Lukkes; Michael J Watt; Christopher A Lowry; Gina L Forster
Journal:  Front Behav Neurosci       Date:  2009-08-20       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.